Serine/threonine-protein kinase MRCK-A Inhibitors (IC50, Ki)

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile	Ki	9524.0 [1]
	1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid	IC50	10000.0 [1]
	7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaene-19-carbonitrile	Ki	6630.0 [1]
	7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile	Ki	4440.0 [1]
	N-(7-Chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetrazatricyclo[16.3.1.05,10]docosa-1(21),5,7,9,18(22),19-hexaen-8-yl)methanesulfonamide	Ki	10000.0 [1]
	CID 46864283	IC50	669.0 [1]
	N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide	IC50	1000.0 [1]
	Chroman 1	IC50	127.0 [1]
	6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one	IC50	10000.0 [1]
	1-(2-Hydroxyethyl)-1-[(3-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea	IC50	4306.0 [1]
	1-[2-(Dimethylamino)ethyl]-1-[(3-methoxyphenyl)methyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea	IC50	8695.0 [1]
	1-[1-(3-Fluorophenyl)-3-hydroxypropyl]-3-[4-(1H-pyrazol-4-yl)phenyl]urea	IC50	6400.0 [1]
	1-[(3-Methoxyphenyl)methyl]-1-methyl-3-[4-(1H-pyrazol-4-yl)phenyl]urea	IC50	1853.0 [1]
	2-Anilino-7-[(1S)-4-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethylpyrrolo[2,3-d]pyrimidin-6-one	IC50	10000.0 [1]
	1-Ethyl-1-[(3-methoxyphenyl)methyl]-3-[2-[(3S)-1-methylpyrrolidin-3-yl]oxy-4-(1H-pyrazol-4-yl)phenyl]urea	IC50	1550.0 [1]
	2-[(1S)-1-Amino-2-(4-fluorophenyl)ethyl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	2-[Amino-(4-methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	2-[(1S)-1-Amino-2-(4-chlorophenyl)ethyl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	2-[(3S,4R)-4-Phenylpyrrolidin-3-yl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	2-[(3S,4R)-4-(4-Chlorophenyl)pyrrolidin-3-yl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	N-[(4-Chlorophenyl)-[4-oxo-6-(1H-pyrazol-4-yl)-3H-quinazolin-2-yl]methyl]-2-(dimethylamino)acetamide	IC50	1000.0 [1]
	2-[(3S,4R)-4-(4-Methoxyphenyl)-1-methylpyrrolidin-3-yl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	2-[(1R)-1-Amino-2-(3-fluorophenyl)ethyl]-8-methoxy-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	2-[Amino-(3-chlorophenyl)methyl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	2-[Amino-(3-chlorophenyl)methyl]-8-methoxy-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	4-(Aminomethyl)-N-[(4-chlorophenyl)-[4-oxo-6-(1H-pyrazol-4-yl)-3H-quinazolin-2-yl]methyl]benzamide	IC50	1000.0 [1]
	2-[(1S)-1-Amino-2-(4-methoxyphenyl)ethyl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	2-[(1R)-1-Amino-2-(4-fluorophenyl)ethyl]-6-(1H-pyrazol-4-yl)-3H-quinazolin-4-one	IC50	1000.0 [1]
	N-(2-(2-(Dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)chroman-3-carboxamide	IC50	210.0 [1]
	N-[2-[2-(Dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2H-chromene-3-carboxamide	IC50	150.0 [1]
	(3R)-N-[2-[2-(Dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide	IC50	5350.0 [1]
	(3R)-N-[2-[2-(Dimethylamino)ethoxy]-5-fluoro-4-(1H-pyrazol-4-yl)phenyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide	IC50	333.0 [1]
	N-(2-(2-(Dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-6-fluorochroman-3-carboxamide	IC50	79.0 [1]
	N-[2-(Dimethylamino)ethyl]-N-[(3-methoxyphenyl)methyl]-6-(1H-pyrazol-4-yl)-1,3-benzothiazole-2-carboxamide	IC50	247.0 [1]
	N-[3-(Dimethylamino)propyl]-3-[6-(1H-pyrazol-4-yl)-1,3-benzothiazol-2-yl]-3,4-dihydro-2H-chromene-6-carboxamide	IC50	9552.0 [1]
	N-Ethyl-N-(3-methoxybenzyl)-6-(1H-pyrazol-4-yl)benzo[d]thiazole-2-carboxamide	IC50	7861.0 [1]
	(3R)-N-[2-[2-(Dimethylamino)ethoxy]-5-fluoro-4-(1H-pyrazol-4-yl)phenyl]-2-ethyl-3,4-dihydro-1H-isoquinoline-3-carboxamide	IC50	810.0 [1]
	N,N-Dimethyl-2-[(3S,4R)-4-phenylpyrrolidin-3-yl]-6-(1H-pyrazol-4-yl)quinazolin-4-amine	IC50	1000.0 [1]
	1-[(3-Hydroxyphenyl)methyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea;methanesulfonic acid	IC50	2.87 [1]
	(3R)-N-[2-[2-(Dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2H-chromene-3-carboxamide	IC50	8640.0 [1]
	(3S)-6-Methoxy-N-[4-(1H-pyrazol-4-yl)-2-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydro-2H-chromene-3-carboxamide	IC50	1275.0 [1]
	(3R)-6-Methoxy-N-[4-(1H-pyrazol-4-yl)-2-(2-pyrrolidin-1-ylethoxy)phenyl]-3,4-dihydro-2H-chromene-3-carboxamide	IC50	20000.0 [1]
	(3S)-6-Methoxy-N-[2-[(3R)-1-methylpyrrolidin-3-yl]oxy-4-(1H-pyrazol-4-yl)phenyl]-3,4-dihydro-2H-chromene-3-carboxamide	IC50	261.0 [1]
	(3R)-6-Methoxy-N-[2-[(3R)-1-methylpyrrolidin-3-yl]oxy-4-(1H-pyrazol-4-yl)phenyl]-3,4-dihydro-2H-chromene-3-carboxamide	IC50	20000.0 [1]
	(3S)-6-Methoxy-N-[2-[(3S)-1-methylpyrrolidin-3-yl]oxy-4-(1H-pyrazol-4-yl)phenyl]-3,4-dihydro-2H-chromene-3-carboxamide	IC50	294.0 [1]
	(3S)-N-[2-(3-Hydroxypropoxy)-4-(1H-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2H-chromene-3-carboxamide	IC50	74.0 [1]

Entire TableStructureCompound NameStandard TypeStandard Values (in nM)

Items per page: 510All1 - 10 of 46 ⟨⟩

---

---

References

This online tool may be cited as follows

MLA	"Quest Database™ Serine/threonine-protein kinase MRCK-A Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 9 May. 2024, https://www.aatbio.com/data-sets/serine-threonine-protein-kinase-mrck-a-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2024, May 9). Quest Database™ Serine/threonine-protein kinase MRCK-A Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/serine-threonine-protein-kinase-mrck-a-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan